Nicola Deidre Petal Greenway

Executive

Insider activity · 24 months0 buys4 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 4 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (4 ops.)

€827k

Latest filing published 19 Aug 2026 for TAKEDA PHARMACEUTICAL CO LTD, €203k. Read the official filing

Filing timeline

BuySale

Nicola Deidre Petal Greenway

Insider track record

Disclosed buys

Disclosed sells

Signal history

Nicola Deidre Petal Greenway: trading record in brief

Nicola Deidre Petal Greenway is a declared insider of Takeda Pharmaceutical Co Ltd, with filings sourced from SEC (Form 4). Between 1 July 2026 and 18 August 2026, the trades on record add up to 5 filings.

The open-market record consists of 4 sales worth €827k, with no purchase. Other entries cover 1 share grant.

Most recently, on 19 August 2026, the filings show an open-market sale worth €203k in Takeda Pharmaceutical Co Ltd. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.